title: Reflux after intravitreal injection of bevacizumab.
authors.forename: Camiel J F
authors.initials: CJ
authors.lastname: Boon
authors.forename: Niels
authors.initials: N
authors.lastname: Crama
authors.forename: B Jeroen
authors.initials: BJ
authors.lastname: Klevering
authors.forename: Frederik J
authors.initials: FJ
authors.lastname: van Kuijk
authors.forename: Carel B
authors.initials: CB
authors.lastname: Hoyng
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014822:Vitreous Body / Q000187:drug effects
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab